Clinical trials: Space Maintenance
Cataract
To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.
The objective of the study is to assess how DisCoVisc Ophthalmic Viscosurgical Device (OVD) compares with Healon and Amvisc Plus in the protection of corneal endothelial cells, and the ability to maintain anterior chamber space…
- Trial name
- NCT00763360
- Testing
- DisCoVisc®, Healon, Amvisc Plus
- Where
- United States
- Volunteers
- 184 people
- Sponsor
- Alcon Research